PRIORIX TETRA subst sèche c solv ser pré
PRIORIX TETRA subst sèche c solv ser pré
PRIORIX TETRA subst sèche c solv ser pré
1 / 3
google

Details

Product number
5815801
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Vaccinum attenuatum: virus morbilli vivus (Stamm: Schwarz) min. 10^3 U., virus parotitis vivus (Stamm: RIT 4385) min.10^4.4 U., virus rubella vivus (Stamm: Wistar RA 27/3) min.10^3 U., virus varicellae vivus (Stamm: OKA) min.10^3.3 U., lactosum, sorbitolum 14 mg, mannitolum, aminoacida cum phenylalaninum 0.583 mg, residui: neomycini sulfas, pro praeparatione. Solvens: aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Articles (1)

Priorix-Tetra, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/05/2026
Professional SmPC
Français
01/05/2026
Professional SmPC
Italien
01/05/2026

Detailed composition

Substance Quantity Type Category
virus morbilli vivus
- Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
virus parotitis vivus
- Substance Wirkstoff (Principe actif)
virus rubella vivus
- Substance Wirkstoff (Principe actif)
virus varicellae vivus
- Substance Wirkstoff (Principe actif)
lactosum
- Substance HNIDK
sorbitolum
14.0 MG Substance HBESI
mannitolum
- Substance HNIDK
aminoacida
- Substance HNIDK
phenylalaninum
0.583 MG Substance HBESI
neomycini sulfas
- Substance RESI

Reimbursement information

Public price
CHF 88.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2020

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
58158
Drug name
Priorix-Tetra, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULMIS
ATC Code
J07BD54
Authorization status
Z
Dispensation category
B
First authorization
02/08/2007
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Masern, Mumps, Röteln und Varizellen, ab dem vollendeten 12. Lebensmonat

Packaging details

Description (FR)
PRIORIX TETRA subst sèche c solv ser pré
Description (DE)
PRIORIX TETRA Trockensub c Solv Fertspr
Market launch
02/08/2009
Narcotic (BTM)
No

Application methods

SUBC IMU
Buy us a coffee Explore the data